Showing results (591-600 of 712) with videos related to
Sort By:
Pageof 72
Cellular & Molecular Immunology|March 16, 2019
Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cellsZhi-Bin Zhao, Fang-Ting Lu, Hong-Di Ma, et al.Journal of Autoimmunity|September 25, 2023
The gut ecosystem and immune toleranceTihong Shao, Ronald Hsu, Desiree L Rafizadeh, et al.Journal of Autoimmunity|August 26, 2003
Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosisHiroto Kita, Aftab A Ansari, Xiao-Song He, et al.Journal of Autoimmunity|November 10, 2009
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosisNancy Agmon-Levin, Yinon Shapira, Carlo Selmi, et al.Hepatology (Baltimore, Md.)|January 29, 2011
B cell depletion therapy exacerbates murine primary biliary cirrhosisAmy Dhirapong, Ana Lleo, Guo-Xiang Yang, et al.Hepatology (Baltimore, Md.)|October 24, 2002
Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosisYasuhiko Kimura, Patrick S c Leung, Thomas P Kenny, et al.Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.Journal of Autoimmunity|June 22, 2020
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, et al.Clinical Reviews in Allergy & Immunology|September 29, 2015
The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune HepatitisFan Yang, Qixia Wang, Zhaoyue Wang, et al.Hepatology (Baltimore, Md.)|October 28, 2003
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacteriumCarlo Selmi, David L Balkwill, Pietro Invernizzi, et al.Pageof 72